Is there an advantage of living over deceased donation in liver transplantation?

Transplant International

Volumn 26, Issue 1, 2013, Pages 11-19

  Quintini, Cristiano ^a   Hashimoto, Koji ^a   Uso, Teresa Diago ^a   Miller, Charles ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

deceased donors; live donors; liver clinical; outcome

Indexed keywords

BILIARY LEAK; CADAVER DONOR; CANCER RECURRENCE; COLD ISCHEMIA; COMPARATIVE STUDY; DECEASED DONOR LIVER TRANSPLANTATION; DONOR; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HEPATIC ARTERY THROMBOSIS; HEPATITIS C; HUMAN; INFORMATION RETRIEVAL; INTRAHEPATIC CHOLESTASIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNPLANNED REEXPLORATION;

CARCINOMA, HEPATOCELLULAR; GRAFT REJECTION; HEPATITIS C; HUMANS; LIVER FAILURE, ACUTE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS;

EID: 84871280300     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01550.x     Document Type: Review

References (86)

1. Gridelli B, Remuzzi G,. Strategies for making more organs available for transplantation. N Engl J Med 2000; 343: 404.
2. Broering DC, Sterneck M, Rogiers X,. Living donor liver transplantation. J Hepatol 2003; 38 (Suppl. 1): S119.
3. Roodnat JI, van Riemsdijk IC, Mulder PG, etal. The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis. Transplantation 2003; 75: 2014.
4. Cronin DC IInd, Millis JM, Siegler M,. Transplantation of liver grafts from living donors into adults-too much, too soon. N Engl J Med 2001; 344: 1633.
5. Thuluvath PJ, Yoo HY,. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl 2004; 10: 1263.
6. Berg CL, Gillespie BW, Merion RM, etal. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007; 133: 1806.
7. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA,. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307.
8. Berg CL, Merion RM, Shearon TH, etal. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology 2011; 54: 1313.
9. Freise CE, Gillespie BW, Koffron AJ, etal. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant 2008; 8: 2569.
10. Merion RM, Shearon TH, Berg CL, etal. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg 2010; 251: 542.
11. Ringe B, Strong RW,. The dilemma of living liver donor death: to report or not to report? Transplantation 2008; 85: 790.
12. Abecassis MM, Fisher RA, Olthoff KM, etal. Complications of living donor hepatic lobectomy-a comprehensive report. Am J Transplant 2012; 12: 1208.
13. Hashikura Y, Ichida T, Umeshita K, etal. Donor complications associated with living donor liver transplantation in Japan. Transplantation 2009; 88: 110.
14. Trotter JF, Adam R, Lo CM, Kenison J,. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006; 12: 1485.
15. Kuo A, Terrault NA,. Management of hepatitis C in liver transplant recipients. Am J Transplant 2006; 6: 449.
16. Berenguer M, Ferrell L, Watson J, etal. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673.
17. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR,. The association between hepatitis c infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889.
18. Wiesner RH, Sorrell M, Villamil F,; International Liver Transplantation Society Expert Panel. Report of the First International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 2003; 9: S1.
19. Everson GT, Trotter J,. Role of adult living donor liver transplantation in patients with hepatitis C. Liver Transpl 2003; 9: S64.
20. Gaglio PJ, Malireddy S, Levitt BS, etal. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 2003; 9: 1028.
21. Garcia-Retortillo M, Forns X, Llovet JM, etal. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004; 40: 699.
22. Fausto N, Campbell JS,. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003; 120: 117.
23. Zimmerman MA, Trotter JF,. Living donor liver transplantation in patients with hepatitis C. Liver Transpl 2003; 9: S52.
24. Schiano TD, Gutierrez JA, Walewski JL, etal. Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology 2005; 42: 1420.
25. Manez R, Mateo R, Tabasco J, Kusne S, Starzl TE, Duquesnoy RJ,. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995; 59: 640.
26. Terrault NA, Shiffman ML, Lok AS, etal. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl 2007; 13: 122.
27. Shiffman ML, Stravitz RT, Contos MJ, etal. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004; 10: 1248.
28. Guo L, Orrego M, Rodriguez-Luna H, etal. Living donor liver transplantation for hepatitis c-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl 2006; 12: 560.
29. Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P,. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients. Liver Transpl 2007; 13: 687.
30. Bozorgzadeh A, Jain A, Ryan C, etal. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation 2004; 77: 1066.
31. Rodriguez-Luna H, Vargas HE, Sharma P, etal. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 2004; 49: 38.
32. Humar A, Horn K, Kalis A, Glessing B, Payne WD, Lake J,. Living donor and split-liver transplants in hepatitis C recipients: does liver regeneration increase the risk for recurrence? Am J Transplant 2005; 5: 399.
33. Selzner N, Girgrah N, Lilly L, etal. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age. Liver Transpl 2008; 14: 1778.
34. Tsoulfas G, Agorastou P,. Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon 2011; 11: 427.
35. Everson GT, Trotter J, Forman L, etal. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 2005; 42: 255.
36. Forns X, Navasa M, Rodes J,. Treatment of HCV infection in patients with advanced cirrhosis. Hepatology 2004; 40: 498.
37. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893.
38. Gondolesi GE, Roayaie S, Munoz L, etal. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004; 239: 142.
39. Mazzaferro V, Regalia E, Doci R, etal. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
40. Yao FY, Ferrell L, Bass NM, etal. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394.
41. Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A,. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology 2001; 33: 1073.
42. Lo CM, Fan ST, Liu CL, Chan SC, Wong J,. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2004; 10: 440.
43. Kulik L, Abecassis M,. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 2004; 127: S277.
44. Fisher RA, Kulik LM, Freise CE, etal. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7: 1601.
45. Marcos A, Fisher RA, Ham JM, etal. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000; 69: 1375.
46. Akamatsu N, Sugawara Y, Kaneko J, etal. Effects of middle hepatic vein reconstruction on right liver graft regeneration. Transplantation 2003; 76: 832.
47. Bhangui P, Vibert E, Majno P, etal. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology 2011; 53: 1570.
48. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG,. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005; 11: 1265.
49. Di Sandro S, Slim AO, Giacomoni A, etal. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Transplant Proc 2009; 41: 1283.
50. Todo S, Furukawa H,; Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240: 451.
51. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J,. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78.
52. Grant D, Fisher RA, Abecassis M, McCaughan G, Wright L, Fan ST,. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation? Liver Transpl 2011; 17 (Suppl. 2): S133.
53. Shirabe K, Taketomi A, Morita K, etal. Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation. Clin Transplant 2011; 25: E491.
54. Sugawara Y, Tamura S, Makuuchi M,. Living donor liver transplantation for hepatocellular carcinoma: Tokyo university series. Dig Dis 2007; 25: 310.
55. Takada Y, Ito T, Ueda M, etal. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig Dis 2007; 25: 299.
56. Bruix J, Fuster J, Llovet JM,. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003; 9: 700.
57. Volk ML, Vijan S, Marrero JA,. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 2008; 8: 839.
58. Pomfret EA, Lodge JP, Villamil FG, Siegler M,. Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations. Liver Transpl 2011; 17 (Suppl. 2): S128.
59. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N,. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21: 240.
60. Polson J, Lee WM,; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41: 1179.
61. Testa G, Malago M, Nadalin S, etal. Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl 2002; 8: 340.
62. Marcos A, Ham JM, Fisher RA, etal. Emergency adult to adult living donor liver transplantation for Fulminant hepatic failure. Transplantation 2000; 69: 2202.
63. Novello AC,. New York State Committee on Quality Improvement in Living Liver Donation. 2002.
64. Campsen J, Blei AT, Emond JC, etal. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2008; 14: 1273.
65. Miwa S, Hashikura Y, Mita A, etal. Living-related liver transplantation for patients with Fulminant and subfulminant hepatic failure. Hepatology 1999; 30: 1521.
66. Nishizaki T, Hiroshige S, Ikegami T, etal. Living-donor liver transplantation for Fulminant hepatic failure in adult patients with a left-lobe graft. Surgery 2002; 131: S182.
67. Liu CL, Fan ST, Lo CM, Yong BH, Fung AS, Wong J,. Right-lobe live donor liver transplantation improves survival of patients with acute liver failure. Br J Surg 2002; 89: 317.
68. Graziadei IW, Wiesner RH, Marotta PJ, etal. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30: 1121.
69. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL,. Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22: 451.
70. Harrison RF, Davies MH, Neuberger JM, Hubscher SG,. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 1994; 20: 356.
71. Kugelmas M, Spiegelman P, Osgood MJ, etal. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003; 9: 727.
72. Sheng R, Campbell WL, Zajko AB, Baron RL,. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease. AJR Am J Roentgenol 1996; 166: 1109.
73. Yamagiwa S, Ichida T,. Recurrence of primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation in Japan. Hepatol Res 2007; 37 (Suppl. 3): S449.
74. Angulo P, Lindor KD,. Primary sclerosing cholangitis. Hepatology 1999; 30: 325.
75. Kaplan MM, Gershwin ME,. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261.
76. Hashimoto E, Shimada M, Noguchi S, etal. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study. Liver Transpl 2001; 7: 588.
77. Hasegawa K, Sugawara Y, Imamura H, Ikeda M, Kokudo N, Makuuchi M,. Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center. Transpl Int 2005; 18: 794.
78. Morioka D, Egawa H, Kasahara M, etal. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007; 13: 80.
79. Hashimoto T, Sugawara Y, Makuuchi M,. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007; 13: 938.
80. LaRusso NF, Shneider BL, Black D, etal. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006; 44: 746.
81. Haga H, Miyagawa-Hayashino A, Taira K, etal. Histological recurrence of autoimmune liver diseases after living-donor liver transplantation. Hepatol Res 2007; 37 (Suppl. 3): S463.
82. Kashyap R, Mantry P, Sharma R, etal. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis. J Gastrointest Surg 2009; 13: 1480.
83. Borozan I, Chen L, Sun J, etal. Gene expression profiling of acute liver stress during living donor liver transplantation. Am J Transplant 2006; 6: 806.
84. Debonera F, Wang G, Xie J, etal. Severe preservation injury induces Il-6/STAT3 activation with lack of cell cycle progression after partial liver graft transplantation. Am J Transplant 2004; 4: 1964.
85. Maluf DG, Stravitz RT, Cotterell AH, etal. Adult living donor versus deceased donor liver transplantation: a 6-year single center experience. Am J Transplant 2005; 5: 149.
86. Liu LU, Bodian CA, Gondolesi GE, etal. Marked differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation 2005; 80: 1072.